SG11202106230XA - Compositions comprising bacterial strains - Google Patents

Compositions comprising bacterial strains

Info

Publication number
SG11202106230XA
SG11202106230XA SG11202106230XA SG11202106230XA SG11202106230XA SG 11202106230X A SG11202106230X A SG 11202106230XA SG 11202106230X A SG11202106230X A SG 11202106230XA SG 11202106230X A SG11202106230X A SG 11202106230XA SG 11202106230X A SG11202106230X A SG 11202106230XA
Authority
SG
Singapore
Prior art keywords
compositions
bacterial strains
strains
bacterial
Prior art date
Application number
SG11202106230XA
Inventor
Imke Elisabeth MULDER
Anna Ettorre
Suaad Ahmed
John Cryan
Ted Dinan
Original Assignee
4D Pharma Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1906728.9A external-priority patent/GB201906728D0/en
Priority claimed from GB201914852A external-priority patent/GB201914852D0/en
Application filed by 4D Pharma Res Ltd filed Critical 4D Pharma Res Ltd
Publication of SG11202106230XA publication Critical patent/SG11202106230XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202106230XA 2018-12-12 2019-12-12 Compositions comprising bacterial strains SG11202106230XA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18212096 2018-12-12
GBGB1906728.9A GB201906728D0 (en) 2019-05-13 2019-05-13 Compositions comprising bacterial strains
GB201914852A GB201914852D0 (en) 2019-10-14 2019-10-14 Compositions comprising bacterial strains
PCT/EP2019/084991 WO2020120714A1 (en) 2018-12-12 2019-12-12 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
SG11202106230XA true SG11202106230XA (en) 2021-07-29

Family

ID=69143494

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202106230XA SG11202106230XA (en) 2018-12-12 2019-12-12 Compositions comprising bacterial strains

Country Status (11)

Country Link
US (1) US20210361722A1 (en)
EP (1) EP3893905A1 (en)
JP (1) JP2022513790A (en)
KR (1) KR20210102927A (en)
CN (1) CN113382740A (en)
AU (1) AU2019398763A1 (en)
CA (1) CA3122338A1 (en)
IL (1) IL283751A (en)
SG (1) SG11202106230XA (en)
TW (1) TW202038979A (en)
WO (1) WO2020120714A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200015575A (en) 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 Compositions Containing Bacterial Strains
TW202014513A (en) 2018-05-11 2020-04-16 英商4D製藥研究有限公司 Compositions comprising bacterial strains
EP4213814A1 (en) 2020-09-18 2023-07-26 Evelo Biosciences, Inc. Solid dosage forms of bacteria
KR20230145050A (en) 2020-12-14 2023-10-17 에벨로 바이오사이언시즈, 인크. Extracellular vesicle preparations
WO2022187578A1 (en) 2021-03-05 2022-09-09 Evelo Biosciences, Inc. Solid dosage forms
KR20240006543A (en) 2021-04-08 2024-01-15 에벨로 바이오사이언시즈, 인크. Pharmaceutical composition containing bacteria
WO2023049268A1 (en) 2021-09-24 2023-03-30 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
WO2023107537A1 (en) 2021-12-07 2023-06-15 Evelo Biosciences, Inc. Antibody compositions and methods for utilizing with extracellular vesicles and microbes
WO2023114293A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Extracellular vesicle assays
WO2023208225A1 (en) * 2022-04-28 2023-11-02 慕恩（广州）生物科技有限公司 Pharmaceutical composition, megasphaera, and use thereof
WO2023208223A1 (en) * 2022-04-28 2023-11-02 慕恩（广州）生物科技有限公司 Pharmaceutical composition, megasphaera, and use thereof
WO2023225635A1 (en) * 2022-05-19 2023-11-23 The Regents Of The University Of California Methods and compositions for improved psychological and resilience measures
WO2024015522A1 (en) 2022-07-13 2024-01-18 Evelo Biosciences, Inc. Methods for analyzing extracellular vesicles and microbes
WO2024076723A1 (en) 2022-10-07 2024-04-11 Evelo Biosciences, Inc. Processing extracellular vesicles
WO2024102226A1 (en) 2022-10-14 2024-05-16 Evelo Biosciences, Inc. Methods for assaying drug substances and drug products by using cell lines with nf-kb- inducible reporter genes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
RU2365621C2 (en) * 2002-07-18 2009-08-27 Эгрикалчарал Рисерч Каунсл Strain megasphaera elsdenii and its application
AU2007310534A1 (en) 2006-10-27 2008-05-02 Capsugel Belgium Nv Hydroxypropyl methyl cellulose hard capsules and process of manufacture
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
FI126711B (en) * 2011-10-12 2017-04-13 Gut Guide Oy Assessing the health risk associated with a serotonin deficiency
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CA2986485A1 (en) * 2015-05-22 2016-12-01 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US9999641B2 (en) * 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
CN110475853A (en) * 2017-01-13 2019-11-19 益福生医股份有限公司 Novel lactic acid bacteria and its application
KR20200015575A (en) * 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 Compositions Containing Bacterial Strains

Also Published As

Publication number Publication date
AU2019398763A1 (en) 2021-07-08
JP2022513790A (en) 2022-02-09
EP3893905A1 (en) 2021-10-20
CN113382740A (en) 2021-09-10
TW202038979A (en) 2020-11-01
WO2020120714A1 (en) 2020-06-18
KR20210102927A (en) 2021-08-20
IL283751A (en) 2021-07-29
WO2020120714A8 (en) 2020-10-01
US20210361722A1 (en) 2021-11-25
CA3122338A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
IL283751A (en) Compositions comprising bacterial strains
SG11202011031UA (en) Compositions comprising bacterial strains
IL277422A (en) Compositions comprising bacterial strains
IL281951A (en) Compositions comprising bacterial strains
IL280895A (en) Compositions comprising bacterial strains
IL279963A (en) Compositions comprising bacterial strains
IL279339A (en) Compositions comprising bacterial strains
IL282439A (en) Compositions comprising bacterial strains
IL279724B (en) Compositions comprising bacterial strains
PT3723777T (en) Compositions comprising bacterial strains
PT3743086T (en) Compositions comprising bacterial strains
GB201820744D0 (en) Compositions comprising bacterial strains
GB201820745D0 (en) Compositions comprising bacterial strains
GB201820264D0 (en) Compositions comprising bacterial strains
GB201820256D0 (en) Compositions comprising bacterial strains
GB201820230D0 (en) Compositions comprising bacterial strains
GB201820261D0 (en) Compositions comprising bacterial strains
GB201817648D0 (en) Compositions comprising bacterial strains
GB201817642D0 (en) Compositions comprising bacterial strains
GB201817641D0 (en) Compositions comprising bacterial strains
GB201814836D0 (en) Compositions comprising bacterial strains
GB201813423D0 (en) Compositions comprising bacterial strains
GB201813460D0 (en) Compositions comprising bacterial strains
GB201812378D0 (en) Compositions comprising bacterial strains
GB201811900D0 (en) Compositions comprising bacterial strains